The spinal cord develops its own pain memory and it may be stoppable
When chronic pain persists long after an injury has healed, many assume the problem lies in the brain.
Neuropathic pain — the burning, shooting, relentless discomfort that follows nerve damage or surgery long after the original injury — affects roughly one in five people worldwide and remains among the hardest conditions to treat. Existing medications offer incomplete relief and often carry serious side effects. Research published in eLife now reveals that the chronic phase of neuropathic pain is sustained, at least in part, by molecular changes in the spinal cord that operate independently of the brain — and through a mechanism that has barely featured in pain research until now.
The mechanism is called translational control: the regulation of which proteins are actually produced from already-made genetic messages (mRNA). In mice with chronic neuropathic pain, the researchers found that gene expression changes in the spinal cord during the chronic phase were governed not primarily at the level of transcription (the making of mRNA) but at the level of translation: which mRNA molecules actually get converted into proteins. It’s a subtle distinction with significant consequences.
Why this changes how pain should be treated
A large portion of existing pain research targets transcription: trying to prevent the production of pain-related mRNA molecules. If the critical regulation happens one step later, those approaches are intervening at the wrong point. The new findings suggest that during chronic pain, the spinal cord actively switches to a different regulatory regime, in which translational mechanisms take over from transcriptional ones.
The researchers identified specific proteins that drive this translational programme, including components of the eIF4F complex — the molecular machinery that initiates protein production. When those components were blocked in mouse models, pain hypersensitivity in the chronic phase fell significantly. Pain didn’t disappear entirely, but allodynia (when even gentle touch becomes painful) was measurably reduced.
Chronic pain as its own disease
What the study demonstrates at a fundamental level is that chronic pain is more than a persistent signal from damaged tissue. The spinal cord develops a self-sustaining molecular state that maintains pain independently of whatever is happening in the original injury site or the brain. That reframes how pain treatment needs to be conceptualised: not as cutting off a signal, but as breaking a self-reinforcing state within the spinal nervous system.
Whether the newly identified targets can be safely and specifically modulated in humans remains unknown. Translational regulation is a core cellular process active in virtually every tissue, and targeted intervention without systemic side effects is a formidable challenge. But the finding redirects the search for future pain medications toward a molecular layer that, until now, has received surprisingly little attention.